In April, there was good news from Bayer Animal Insurance, that the professional managers and consulting companies hired by the Chinese consortium had finally straightened out their business and paid the final balance of the equity transaction.

The $8 billion deal, counting the early contact and the later handover, took nearly a year.

For such a large acquisition, the time taken is not too long, and it can only be said to be average.

The larger the case, the more complex the business and people involved.

Due diligence is important to prevent you from stepping on pitfalls, and handover is also important to ensure a smooth transition between people and business.

Tens of billions of yuan have been spent, so it is natural to be cautious.

Zhang Yida and the other two investment institutions did not urge, and have been patiently integrating with professional managers.

Now that the integration work is over, it's time to put on a show of real technology.

So, Zhang Yida invited Shen Beipeng and Zhang Sanshi to Pete.com, ready to talk about the next "assembly work".

Lu Fenghai, as the CEO of Pate Holdings, also came to the meeting.

Looking at the three bigwigs Zhang Yida, Shen Beipeng, and Zhang Sanshi sitting on the field, he couldn't help but feel a little excited.

These are all tycoons who can stomp their feet in China's Internet circle and venture capital circle.

Sitting here today, on one theme, assemble Pate Holdings into a super unicorn in the pet world.

Lu Fenghai felt that the most correct thing he had done in his life was to accept the recommendation of angel investor Xu Xiaoming after the failure of his business, join Zhang Yida, and build Pete from scratch, and then to today's Pete Holding Group.

Pete Holding Group has a poor reputation, not as good as star companies such as Ruixiang and Yimin Wangjin, but it can be regarded as an old unicorn.

In the pet world, that's a well-deserved overlord.

Last year, Lu Fenghai knew that Zhang Yida had formed a Chinese-funded consortium to acquire Bayer Animal Insurance.

At the same time, he also knew that Bayer Animal Protection would be installed in the Pate holding system to create a unicorn with a market value of 100 billion.

But there has been no specific action, and he can only be anxious on the sidelines.

However, there was one thing that reassured him a lot.

Bayer Animal Insurance's drugs are continuously on the shelves of the Pate online store, and the shelves of Pate Hospital offline are also Bayer Animal Health drugs.

Pat Pharmaceutical, a joint venture company jointly established with Jingda Medical Group, a subsidiary of Jingda Founder, is also continuously obtaining medical authorization from Bayer Animal Health to study some domestic generic drugs.

By all indications, the day of the merger is very close.

Today, it's finally time to kick things off.

Zhang Yida, Shen Beipeng, and Zhang Sanshi have been chatting about the next moves, and he listened quietly on the side.

"Feng Hai, let's see the achievements of Pate Holdings in recent years. ”

After chatting for a while, Zhang Yida felt that it was almost over, and it was time to serve the main dish.

Lu Fenghai nodded, and under the gaze of the three people, he began to display the PPT.

"Pate Holdings currently has four major subsidiaries, the pet e-commerce brand Pite.com, the pet medical brand Pate Pet Hospital, the pet food brand Dogfud holding 51, and Pate Pharmaceutical, which holds 80. ”

Shen Beipeng and Zhang Sanshi glanced at each other and nodded, recognizing the business layout of Pate Holdings.

Zhang Yida always has a faint smile on his face, and the layout of more than five years has finally ushered in the moment of harvest.

Seeing that the three of them had no questions to ask, Lu Fenghai continued: "The GV of Peite.com in 2018 is 21.2 billion yuan, and this year it is expected to be between 28 billion yuan and 30 billion yuan. ”

Lu Fenghai pulled up charts one after another, and the GV of each month was clearly marked in the bar chart, and there was a steep upward curve next to it.

The black-shirt capital behind Shen Beipeng was originally a shareholder of Peter.com, and he read the annual performance statement, so it was not strange at this time.

Zhang Sanshi was different, he was slightly moved, and then suddenly realized: "No wonder, I heard that many pet sellers on Taobao and Tmall have come to Pete to open stores, the rumors are true, haha"

Lu Fenghai smiled modestly, "It's okay, they have a volume advantage there, and vertical e-commerce can't monopolize the sale of pet products."

We have launched mini programs on Doushi, Kuaishou, and Xiaohongshu, and put a lot of short video advertising materials, which has now become a new performance growth point for Peite.com.

In addition, several live broadcast platforms under Ruixiang have also been connected to Pete.com, and live streaming is also our new power point.

There is also Pindodo, which is a strategic partnership with us, and Dogfud has a store in Pindodo. ”

Zhang Sanshi glanced at Zhang Yida, it was really enough to make a lot of money

Zhang Yida laughed, "Normal cooperation, normal cooperation, the money that should be given is not less." ”

How dare Zhang Yida engage in any insider trading, Ruixiang is so large, and there are so many pairs of eyes staring up and down.

However, Peite.com does enjoy a lot of benefits brought by Zhang Yida, a major shareholder, and other e-commerce platforms can't share the traffic of the Ruixiang system even if they come with money.

Ruixiang Industrial Investment Fund has also invested in Pate Holdings, and it is reasonable to cooperate closely.

Lu Fenghai continued: "Pate Pet Hospital has opened 284 chain hospitals in China, all of which are located in first- and second-tier cities.

Dogfud's revenue in 2018 was 32.5 billion and net profit was 5.2 billion. ”

Speaking of this, Lu Feng paused and added: "When we acquired Dogford three years ago, we signed a VAM agreement.

Dogford is required to achieve a net profit of not less than 11.4 billion yuan in three years, and the VAM has been overcompleted. ”

Shen Beipeng nodded, "This is a very good deal, and I got the shares of Dogfu 51 at the price of an additional $5.1 billion in equity.

Dogfud's steady stream of profits greatly supported Pate Hospital's expansion plans. ”

Zhang Sanshi nodded slightly, he also knew about it, and he also knew that Dogford was originally Zhang Yida's family business, which had been run by Zhang Yida's father, Zhang Qinghua.

"What's the situation with Pat Pharmaceutical?"

Zhang Sanshi wondered, "Isn't Jingda Medical Group a doctor?"

Zhang Yida explained aloud, "Jingda Medical Group is a sub-group of Founder, and in addition to hospitals, there are also pharmaceutical companies.

In fact, pets and people can share some medicines, so we are cooperating with them in this regard.

At that time, Bayer Animal Insurance had not yet been acquired, so I wanted to make up for the shortcomings of medicine. ”

"Are there any new drugs developed?" Zhang Sanshi asked, this question is very critical, and the most important thing for pharmaceutical groups is R&D capabilities.

If a new drug is developed, it will really be a rolling profit.

Lu Fenghai shook his head, "After all, it is not a professional veterinary drug, it is mainly in the development of some alternative drugs, and after Bayer's authorization, it is imitating some low-cost domestic veterinary drugs." ”

Zhang Sanshi nodded very understandingly, biomedical technology is indeed a big step behind the international first-class level in China.